Drug Profile
Research programme: ASK1 inhibitors - Calchan
Latest Information Update: 08 Sep 2023
Price :
$50
*
At a glance
- Originator Calchan
- Class
- Mechanism of Action MAP kinase kinase kinase 5 inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- Discontinued Inflammation; Pain
Most Recent Events
- 08 Sep 2023 Discontinued - Preclinical for Inflammation in United Kingdom (PO)
- 08 Sep 2023 Discontinued - Preclinical for Pain in United Kingdom (PO)
- 28 Jun 2019 No recent reports of development identified for preclinical development in Inflammation in United Kingdom (PO)